State NY
Clinical Trials in New York
Recruiting clinical trials with at least one study location in New York. Data updated daily from ClinicalTrials.gov.
Top Conditions in New York
Frequently Asked Questions — Clinical Trials in New York
How many clinical trials are currently recruiting in New York?
ClinicalMetric currently tracks 667 actively recruiting clinical trials with at least one location in New York. The total number of registered studies—including active but not currently enrolling trials—is 667. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New York?
New York hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Multiple Myeloma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New York serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New York?
To join a clinical trial in New York, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New York maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New York
NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06561386 Phase 3
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs...
Condition
Non-small Cell Lung Cancer
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06016842 Phase 3
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Chol...
Condition
Primary Biliary Cholangitis (PBC)
Enrollment
276 pts
Location
United States, Argentina, Australia
Sponsor
Ipsen
NCT07420283 Phase 2
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Condition
Opioid Use Disorder
Enrollment
465 pts
Location
United States, Canada, Puerto Rico
Sponsor
Eli Lilly and Company
NCT07261722 N/A
Recruiting
Collaborative Opportunities for Reducing Alcohol and Sexual Violence Together
Condition
Sexual Violence
Enrollment
132 pts
Location
United States
Sponsor
State University of New York a
NCT07390331 N/A
Recruiting
A Patient Activation Approach to Implementing Depression Treatment in Cardiac Pa...
Condition
Depression and CVD
Enrollment
200 pts
Location
United States
Sponsor
Columbia University
NCT06227377 Phase 1
Recruiting
QTX3034 in Patients With KRAS G12D Mutation
Condition
Solid Tumors
Enrollment
250 pts
Location
United States
Sponsor
Quanta Therapeutics
NCT06517875 Phase 2
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Trans...
Condition
Primary Myelofibrosis
Enrollment
68 pts
Location
United States, Canada, France
Sponsor
GlaxoSmithKline
NCT06858579 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic In...
Condition
Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment
256 pts
Location
United States, Argentina, Australia
Sponsor
Dianthus Therapeutics
NCT06201429 N/A
Recruiting
A Multi-center, Early Feasibility Study of Using the Mechanical Tissue Resuscita...
Condition
Clinical Need for Craniotomy or Craniectomy
Enrollment
11 pts
Location
United States
Sponsor
Renovo Concepts, Inc.
NCT03961945 N/A
Recruiting
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus...
Condition
Barrett Esophagus
Enrollment
1,550 pts
Location
United States
Sponsor
Mayo Clinic
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
NCT06724627 N/A
Recruiting
Application of the Belle.AI Dermatological Image Reference System for Patient Di...
Condition
Skin Condition
Enrollment
263 pts
Location
United States
Sponsor
BelleTorus Corporation
NCT03424005 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in...
Condition
Metastatic Breast Cancer
Enrollment
792 pts
Location
United States, Australia, France
Sponsor
Hoffmann-La Roche
NCT03821129 N/A
Recruiting
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reducti...
Condition
Stroke
Enrollment
636 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT06472245 Phase 3
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung...
Condition
Patients With Non-Small Cell Lung Cancer
Enrollment
363 pts
Location
United States, Belgium, Canada
Sponsor
OSE Immunotherapeutics
NCT05429970 N/A
Recruiting
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian...
Condition
Ovarian Cancer
Enrollment
35 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT02193841 Phase 3
Recruiting
Simple Bone Cysts in Kids
Condition
Bone Cyst
Enrollment
160 pts
Location
United States, Australia, Canada
Sponsor
The Hospital for Sick Children
NCT00707694 N/A
Recruiting
The Longevity Genes in Founder Populations Project
Condition
Extreme Longevity
Enrollment
2,000 pts
Location
United States
Sponsor
Albert Einstein College of Med
NCT06162221 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Condition
Non-Small Cell Lung Cancer, NSCLC
Enrollment
616 pts
Location
United States, Australia, Denmark
Sponsor
Revolution Medicines, Inc.
NCT04899947 N/A
Recruiting
Child and Adolescent Registry for Participants With Narcolepsy
Condition
Narcolepsy
Enrollment
500 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
NCT05490225 N/A
Recruiting
Access Cannulation Trial II
Condition
Dialysis; Complications
Enrollment
100 pts
Location
United States
Sponsor
Voyager Biomedical
NCT05264857 N/A
Recruiting
Decision Aid and Thyroid Nodules Management
Condition
Thyroid Nodule
Enrollment
134 pts
Location
United States
Sponsor
Stony Brook University
NCT07356492 N/A
Recruiting
Expanding Veteran Sponsorship Initiative+ to Support High-Risk Transitioning Ser...
Condition
Reintegration Difficulties
Enrollment
2,700 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06476132 Phase 2
Recruiting
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung...
Condition
Lung Transplant
Enrollment
234 pts
Location
United States, Canada
Sponsor
National Institute of Allergy
Page 1 of 27 — 667 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology